High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.
We investigated maternal antibody (MatAb) effects on protection and immune responses to rotavirus vaccines. Gnotobiotic pigs were injected intraperitoneally at birth with pooled serum from sows hyperimmunized with human rotavirus (HRV); control pigs received no sow serum. Pigs with or without MatAbs received either sequential attenuated HRV (AttHRV) oral priming and intranasal boosting with VP2/VP6 virus-like particle (VLP)-immunostimulating complex (ISCOM) (AttHRV/VLP) or intranasal VLP-ISCOM prime/boost (VLP) vaccines at 3 to 5 days of age. Subsets of pigs were challenged at 28 or 42 days postinoculation with virulent Wa HRV to assess protection. Isotype-specific antibody-secreting cell (ASC) responses to HRV were quantitated by enzyme-linked immunospot assay to measure effector and memory B-cell responses in intestinal and systemic lymphoid tissues pre- and/or postchallenge. Protection rates against HRV challenge (contributed by active immunity and passive circulating MatAbs) were consistently (but not significantly) lower in the MatAb-AttHRV/VLP groups than in the corresponding groups without MatAbs. Intestinal B-cell responses in the MatAb-AttHRV/VLP group were most suppressed with significantly reduced or no intestinal immunoglobulin A (IgA) and IgG effector and memory B-cell responses or antibody titers pre- and postchallenge. This suppression was not alleviated but was enhanced after extending vaccination/challenge from 28 to 42 days. In pigs vaccinated with nonreplicating VLP alone that failed to induce protection, MatAb effects differed, with intestinal and systemic IgG ASCs and prechallenge memory B cells suppressed but the low intestinal IgA and IgM ASC responses unaffected. Thus, we demonstrate that MatAbs differentially affect both replicating and nonreplicating HRV vaccines and suggest mechanisms of MatAb interference. This information should facilitate vaccine design to overcome MatAb suppression.
Nguyen
Trang V
TV
Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, 1680 Madison Avenue, Wooster, OH 44691-4096, USA.
Yuan
Lijuan
L
Azevedo
Marli S P
MS
Jeong
Kwang-il
KI
Gonzalez
Ana M
AM
Iosef
Cristiana
C
Lovgren-Bengtsson
Karin
K
Morein
Bror
B
Lewis
Peggy
P
Saif
Linda J
LJ
D000818:Animals; D000831:Animals, Newborn; D000914:Antibodies, Viral / Q000008:administration & dosage / Q000097:blood*; D001402:B-Lymphocytes / Q000276:immunology* / Q000821:virology; D003967:Diarrhea / Q000276:immunology / Q000517:prevention & control / Q000821:virology; D005260:Female; D006801:Humans; D016882:ISCOMs / Q000008:administration & dosage / Q000276:immunology*; D007112:Immunity, Maternally-Acquired; D007117:Immunization, Secondary; D007156:Immunologic Memory; D007223:Infant; D007231:Infant, Newborn; D007274:Injections, Intraperitoneal; D012401:Rotavirus / Q000276:immunology; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D013552:Swine; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D014771:Virion / Q000276:immunology*
D000914:Antibodies, Viral; D016882:ISCOMs; D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated